Fraunhofer Institute for Cell Therapy and Immunology (IZI) at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Fraunhofer Institute for Cell Therapy and Immunology (IZI) brings 8 presentations to ESGCT 2026 in Hamburg. Its work centres on engineering immune cells with Sleeping Beauty transposons rather than viral vectors, and on CAR T and NK cell products for acute leukaemia. A second strand works on quality-by-design AAV production for clinical-grade supply.

OrganizationESGCT 2026 Attendance
Universities & institutes
Fraunhofer institute that develops and GMP-manufactures cell and gene therapies, including Sleeping Beauty transposon-engineered CAR-T cells.
Chair
Tue Oct 27
2:00pm–4:30pm
SESSION 1: ESGCT 2026 Opening: Clinical applications of gene therapy
with Tigem, University of Hamburg
Clinical trials and translation
Talk
Wed Oct 28
8:30am–10:30am
Advances in Sleeping Beauty transposon-based therapeutic cell engineering
SESSION 3d: Non-viral vectors/nanotechnology and RNA therapeutics I
Vectors and delivery (AAV, lentiviral, LNP)Cell therapies and CAR-T
Poster
Wed Oct 28
1:30pm–3:30pm
Genetic Engineering of NK Cells for Targeted Therapy Against Acute Myeloid Leukemia
Immunotherapy and CAR T cells
Poster
Wed Oct 28
1:30pm–3:30pm
Next generation manufacturing of CAR T cells: Easy workflow integration for gene therapy (EASYGEN)
Immunotherapy and CAR T cells
Poster
Wed Oct 28
1:30pm–3:30pm
Quality by Design–driven AAV transfection: Defining a design space for scalable, cost-effective GMP manufacturing
AAVs / non integrative vectors
Chair
Thu Oct 29
11:00am–1:00pm
SESSION 8: Presidential Symposium
with Tigem
Poster
Thu Oct 29
2:00pm–4:00pm
Activation State Determines Base Editing Competence in Primary NK Cells
Immunotherapy and CAR T cells
Poster
Thu Oct 29
2:00pm–4:00pm
Antibody-mediated enhancement of AAV2 transduction in primary monocyte-derived dendritic cells
AAVs / non integrative vectors
Poster
Thu Oct 29
2:00pm–4:00pm
CAR FINDER: Revolutionizing CAR T cells
Immunotherapy and CAR T cells
Poster
Thu Oct 29
2:00pm–4:00pm
Leaving SB100X behind – Development of a new hyperactive Sleeping Beauty transposase for cell engineering
Gene Editing
Chair
Thu Oct 29
4:00pm–6:00pm
SESSION 9d: Manufacturing
with Complement Therapeutics
Manufacturing, CMC and access
Chair
Fri Oct 30
11:00am–1:00pm
SESSION 12d: Non-viral vectors/Nanotechnology and RNA therapeutics II
with University of Groningen
Vectors and delivery (AAV, lentiviral, LNP)RNA and oligonucleotide therapies

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Fraunhofer Institute for Cell Therapy and Immunology (IZI)

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction